AKUOS
AKUOS is a product that helps augment human capabilities and allows people to overcome physical limitations caused by conditions such as hearing loss. Designers use technology to optimise everyday life and human experiences through excellent quality, stylish, and seamless product solutions that enable our customers to live their best lives through human-centric engineering and design processes. Using cutting-edge engineering, artificial intelligence, and manufacturing, designers create devices that enable people to be and do more, addressing not only disabilities but also expanding their capabilities.
AKUOS
Industry:
Artificial Intelligence (AI)
Founded:
2017-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.akuos.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
883.45 K USD
Technology used in webpage:
Euro Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator GoDaddy Premium DNS
Similar Organizations
Current Employees Featured
Founder
Investors List
Verge HealthTech Fund
Verge HealthTech Fund investment in Seed Round - AKUOS
0711 Venture
0711 Venture investment in Pre Seed Round - AKUOS
LINvestment
LINvestment investment in Pre Seed Round - AKUOS
More informations about "AKUOS"
About Us - Akouos
At Akouos (ah KOO ohs), we strive to be a team that listens to one another, to healthcare providers, and to the deaf and hard of hearing (DHH) community. Our partnerships and …See details»
Akouos - Crunchbase Company Profile & Funding
Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and …See details»
Our Focus – Akouos
The Akouos founding team has over 100 years of combined research experience characterizing inner ear structure-function relationships. The work of co-founder Dr. Richard J. Smith, world-renowned for his scientific and clinical expertise in …See details»
Akouos - Overview, News & Similar companies | ZoomInfo.com
Who is Akouos. Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acu ity physiologic hearing …See details»
Akouos Company Profile 2024: Valuation, Investors, …
Akouos General Information Description. Akouos Inc is a genetic medicine company focused on developing gene therapies that restore, improve, and preserve hearing. The company is involved in developing potential genetic …See details»
Lilly to Acquire Akouos to Discover and Develop …
Oct 18, 2022 CVR holders would become entitled to receive contingent payments as follows: (i) $1.00 in cash, upon the fifth (5th) participant being administered with AK-OTOF in a Phase 1 or Phase 1/2 trial on or prior to Dec. …See details»
Akouos Inc Company Profile - Overview - GlobalData
Akouos Inc, a subsidiary of Eli Lilly and Co, develops gene therapies to restore and preserve high-acuity physiologic hearing for disabling hearing loss patients. The company is headquartered …See details»
Akouos - VentureRadar
" Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals …See details»
AKOUOS: Shareholders Board Members Managers and Company …
Akouos Inc. precision genetic medicine company focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals. The …See details»
Akouos Company Profile - Office Locations, Competitors ... - Craft
Akouos is a precision genetic medicine company focused on developing gene therapies to treat hearing disorders. It advances candidate therapies that target sensory cells, such as inner hair …See details»
Akouos - Funding, Financials, Valuation & Investors - Crunchbase
Akouos is registered under the ticker NASDAQ:AKUS . Their stock opened with $17.00 in its Jun 25, 2020 IPO. Akouos is funded by 15 investors. Fidelity and PAG are the most recent …See details»
Akouos, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Akouos, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 62 news, and 9 literature, Disease Domain:Nervous System Diseases, Neoplasms, …See details»
Lilly Completes Acquisition of Akouos Expanding Efforts to Help …
Dec 1, 2022 Under the terms of the contingent value rights agreement, CVR holders would become entitled to receive contingent payments as follows: (i) $1.00 in cash, upon the fifth …See details»
Akouos - Contacts, Employees, Board Members, Advisors
Organization. Akouos . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board …See details»
Akouos CEO and Key Executive Team | Craft.co
Akouos's CEO & Co-Founder is Emmanuel Simons. Other executives include Michael McKenna, Chief Surgical Officer & Co-Founder; Kathy Reape, Chief Medical Officer and 4 others. See …See details»
Akouos - workinbiotech.com
Akouos is developing AAV-based gene therapies to treat hearing loss that results from mutations in genes for inner ear function. Akouos uses specialized vectors and surgical procedures to …See details»
Lilly to Acquire Akouos to Discover and Develop Treatments for …
Oct 18, 2022 CVR holders would become entitled to receive contingent payments as follows: (i) $1.00 in cash, upon the fifth (5th) participant being administered with AK-OTOF in a Phase 1 …See details»
Akouos Announces Key Leadership Appointments
Oct 1, 2020 Akouos Announces Key Leadership Appointments October 1, 2020 BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (NASDAQ: AKUS), a precision genetic …See details»
Akouos: A Bold Step Towards Treat Hearing Loss with Genetic …
Apr 22, 2021 Last week, Akouos, Inc. (pronounced Ah-KOO-os), a Boston-based biopharmaceutical company, was granted both Orphan Drug Designation (ODD) and Rare …See details»